Alphamab Oncology (HK:9966) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alphamab Oncology has appointed Mr. Cho Man as a non-executive director and a member of its strategy committee, effective October 22, 2024, bringing his extensive experience in the pharmaceutical industry to the company. The company also announced the resignation of Ms. Wang Jin’nan as joint company secretary due to other work commitments. These changes are part of Alphamab’s strategic efforts to strengthen its leadership team for future growth.
For further insights into HK:9966 stock, check out TipRanks’ Stock Analysis page.